10.29
price up icon0.39%   0.04
after-market Handel nachbörslich: 10.29
loading
Schlusskurs vom Vortag:
$10.25
Offen:
$10.23
24-Stunden-Volumen:
1.59M
Relative Volume:
0.99
Marktkapitalisierung:
$3.23B
Einnahmen:
$2.68B
Nettoeinkommen (Verlust:
$-184.45M
KGV:
-15.12
EPS:
-0.6805
Netto-Cashflow:
$229.23M
1W Leistung:
+0.00%
1M Leistung:
+5.54%
6M Leistung:
+35.04%
1J Leistung:
+20.49%
1-Tages-Spanne:
Value
$10.13
$10.45
1-Wochen-Bereich:
Value
$10.13
$10.62
52-Wochen-Spanne:
Value
$6.685
$10.68

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
Firmenname
Amneal Pharmaceuticals Inc
Name
Telefon
908-947-3120
Name
Adresse
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
Mitarbeiter
5,210
Name
Twitter
@amnealpharma
Name
Nächster Verdiensttermin
2025-05-02
Name
Neueste SEC-Einreichungen
Name
AMRX's Discussions on Twitter

Vergleichen Sie AMRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
10.29 3.22B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.41 65.38B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.10 44.75B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.12 40.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.78 22.50B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
415.34 19.04B 3.08B 1.24B 1.07B 25.61

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-06 Eingeleitet Goldman Buy
2025-02-24 Hochstufung JP Morgan Neutral → Overweight
2024-09-06 Hochstufung JP Morgan Underweight → Neutral
2021-04-07 Fortgesetzt RBC Capital Mkts Sector Perform
2021-03-08 Hochstufung Goldman Sell → Buy
2020-12-14 Hochstufung Barclays Equal Weight → Overweight
2020-12-14 Hochstufung Guggenheim Neutral → Buy
2020-07-27 Eingeleitet Goldman Sell
2020-05-12 Hochstufung Guggenheim Sell → Neutral
2019-12-12 Herabstufung Raymond James Outperform → Mkt Perform
2019-11-12 Herabstufung JP Morgan Neutral → Underweight
2019-11-07 Herabstufung SVB Leerink Outperform → Mkt Perform
2019-07-22 Hochstufung SVB Leerink Mkt Perform → Outperform
2019-07-11 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2019-07-08 Hochstufung Piper Jaffray Neutral → Overweight
2019-06-11 Eingeleitet Barclays Equal Weight
2019-05-21 Hochstufung Raymond James Mkt Perform → Strong Buy
2019-03-20 Eingeleitet SunTrust Buy
2019-03-08 Herabstufung SVB Leerink Outperform → Mkt Perform
2018-12-14 Herabstufung Morgan Stanley Overweight → Equal-Weight
2018-10-16 Herabstufung SunTrust Buy → Hold
2018-08-13 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2018-07-23 Eingeleitet Morgan Stanley Overweight
2018-06-22 Eingeleitet B. Riley FBR, Inc. Buy
Alle ansehen

Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten

pulisher
03:19 AM

Will Amneal Pharmaceuticals Inc. stock reach Wall Street targets2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

03:19 AM
pulisher
01:44 AM

Does Amneal Pharmaceuticals Inc. show high probability of rebound2025 Buyback Activity & Fast Gain Swing Alerts - newser.com

01:44 AM
pulisher
01:41 AM

Is Amneal Pharmaceuticals Inc. stock resilient to inflationMarket Volume Summary & Technical Pattern Alert System - newser.com

01:41 AM
pulisher
01:02 AM

Is Amneal Pharmaceuticals Inc. stock a top momentum playTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com

01:02 AM
pulisher
12:36 PM

How high can Amneal Pharmaceuticals Inc. stock go2025 Earnings Impact & AI Enhanced Trading Signals - newser.com

12:36 PM
pulisher
12:34 PM

Will Amneal Pharmaceuticals Inc. stock benefit from automationWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com

12:34 PM
pulisher
12:03 PM

Can Amneal Pharmaceuticals Inc. stock beat market expectations this quarterJuly 2025 Big Picture & Safe Swing Trade Setups - Fundação Cultural do Pará

12:03 PM
pulisher
Oct 27, 2025

How Amneal Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trend Report & Free Long-Term Investment Growth Plans - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

How to manage a losing position in Amneal Pharmaceuticals Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Mycophenolate Pregnancy Registry: Key Insights for Investors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

What analyst consensus says on Amneal Pharmaceuticals Inc. stockWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Amneal Launches Brekiya®the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Candlestick signals on Amneal Pharmaceuticals Inc. stock todayJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Amneal (NASDAQ: AMRX) launches Brekiya for migraine, exclusive at Walgreens and Sterling - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 03:37:22 - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 15:52:31 - newser.com

Oct 26, 2025

Finanzdaten der Amneal Pharmaceuticals Inc-Aktie (AMRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$47.12
price down icon 2.30%
$22.12
price down icon 0.67%
$10.29
price down icon 1.25%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 0.90%
$147.38
price down icon 1.05%
$415.34
price down icon 1.35%
Kapitalisierung:     |  Volumen (24h):